Orthopedic Design & Technology, a publication serving the field of orthopedic product development and manufacturing, has named Reflexion Health among its ‘Orthopedic Technology Innovators of Note’ — an exclusive list of six innovators “disrupting ‘tried and true’ care protocols and offering what could be more effective alternatives.”
“Behavior-driven development is essential for our patient- and clinician-facing solutions, having us focus on engagement and ease of use as opposed to mere functionality,” Dr. Joe Smith told Forbes. “My advice would be to do whatever it takes to get the users (for us, patients and clinicians) involved early in the product development,” he adds, “and don’t stop tweaking until they are delighted!”
Reflexion Health President Dr. Joe Smith was one of the experts recently consulted by Becker’s ASC about how healthcare leaders can best manage the transition to the bundled payments model in a way that’s most likely to yield the highest possibility of reward along with the lowest level of risk.
In a guest blog post recently published at Medical Economics, Reflexion Health President and CEO Dr. Joe Smith takes a look at “what’s working” and “what isn’t” about the healthcare industry’s ongoing transition to value-based care — and what may be in store in the years to come.
Writing at Forbes, Reflexion Health President and CEO and Forbes Technology Council member Dr. Joseph “Joe” Smith has published a new article describing how healthcare providers and leaders can better achieve the goal of offering care that’s truly “patient-centered.”
The Forbes Technology Council recently weighed in on the potential consequences of government regulation of the U.S. technology industry, with council member Dr. Joe Smith writing that an “unintended consequence of burdensome regulatory frameworks is often a slowing of innovation.”
Our CEO Dr. Joseph “Joe” Smith recently sat down with Becker’s ASC to discuss the evolving reimbursement situation for ASC businesses, in a conversation that ranged from the prevalence of risk-based contracts and price transparency to strategies for approaching payor negotiations and more.
The FDA News has now officially reported that we’ve received 510(k) clearance for the use of our VERA™ digital PT assistant for “rehabilitating the trunk and upper extremities,” an extension of our earlier FDA clearance for the treatment of lower extremities (i.e., knee and hip replacement surgery).